Opaleye Management Inc. Selecta Biosciences Inc Transaction History

Opaleye Management Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.89 - $4.43 $306,340 - $469,579	-106,000 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$3.36 - $4.62 $356,160 - $489,720	106,000 New	106,000 $441,000
Q2 2020 Aug 14, 2020	SELL	$1.83 - $4.06 $713,700 - $1.58 Million	-390,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$1.5 - $4.52 $585,000 - $1.76 Million	390,000 New	390,000 $940,000
Q4 2017 Feb 09, 2018	SELL	$8.97 - $23.38 $852,150 - $2.22 Million	-95,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$15.22 - $20.03 $1.45 Million - $1.9 Million	95,000	95,000 $1.73 Million

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

Stay updated on Opaleye Management Inc. with notifications on news.